While a shortage of specialized talent in regulatory and clinical domains remains a challenge, the industry is successfully evolving toward a more efficient, data-driven expansion. Our latest report explores the rise of niche expertise and provides a cautiously optimistic outlook for the biologics and precision medicine sectors in 2026. Download the full analysis to stay ahead of the specialized talent trends shaping the year ahead.